This trial will investigate whether gabapentin can correct an imbalance of neurotransmitters in the brain to improve social cognition in adolescents with autism spectrum disorder.
1 Primary · 0 Secondary · Reporting Duration: 8 weeks
Side Effects for
1 Treatment Group
Gabapentin Open-label treatment
1 of 1
40 Total Participants · 1 Treatment Group
Primary Treatment: Gabapentin · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 13 - 17 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||66.7%|
What site did they apply to?
|University of Massachusetts Medical School||100.0%|
What portion of applicants met pre-screening criteria?
|Did not meet criteria||42.9%|
How responsive is this trial?
Typically responds via
Average response time
- < 1 Day
Most responsive sites:
- University of Massachusetts Medical School: < 24 hours
Frequently Asked Questions
Is the research open for enrollment at present?
"Indeed, the data stored on clinicaltrials.gov states that this clinical trial is still recruiting individuals. It was first listed on February 4th 2022 and has been updated as recently as April 4th 2022 with a goal of admitting 40 patients to be observed at 1 medical site." - Anonymous Online Contributor
Does using Gabapentin pose any health risks to individuals?
"There is an existing body of evidence attesting to the safety and efficacy of Gabapentin, thus it was awarded a score of 3." - Anonymous Online Contributor
Do I meet the necessary qualifications to participate in this research?
"This study requires 40 adolescents, aged 13-17 years old and with IQ scores greater than 70 according to the Weschler Abbreviated Scale of Intelligence (WASI), who are also diagnosed with autism spectrum disorder." - Anonymous Online Contributor
How many participants are included in this experiment?
"Affirmative. Clinicaltrials.gov documents that this experiment, initially posted on February 4th 2022 and most recently revised April 4th 2022, is actively seeking participants. 40 patients from a single site will be required for the trial." - Anonymous Online Contributor
Has there been any research conducted concerning the efficacy of Gabapentin?
"Currently, there are 25 Gabapentin-centric clinical trials in the works with 9 of them being on Phase 3. Much of this research is centered around Columbus, Ohio; however, 67 other sites have also been enlisted for these studies." - Anonymous Online Contributor
For what ailments is Gabapentin frequently prescribed?
"Gabapentin can be deployed to mitigate the symptoms of neuralgia, epilepsies, and postherpetic neuralgia." - Anonymous Online Contributor
Is the age range for this trial inclusive of those aged 35 and up?
"The requirements for inclusion in this trial necessitate that potential participants are between 13 and 17 years old. 231 studies exist which involve minors, while 60 trials cater to people over 65." - Anonymous Online Contributor